SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 321.35 |
| Enterprise Value ($M) | 364.27 |
| Book Value ($M) | 3.29 |
| Book Value / Share | 0.18 |
| Price / Book | 97.74 |
| NCAV ($M) | -25.59 |
| NCAV / Share | -1.43 |
| Price / NCAV | -12.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.14 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.98 |
| Current Ratio | 2.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 135.10 |
| Assets | 163.98 |
| Liabilities | 160.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 179.28 |
| Operating Income | 24.19 |
| Net Income | 17.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 31.47 |
| Cash from Investing | 4.13 |
| Cash from Financing | -11.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 6.54 | -25.00 | |
| 13G/A | Soleus Capital Master Fund, L.P. | 6.40 | 20.96 | |
| 13G/A | Invesco Ltd. | 0.00 | -99.39 | |
| 13G | BlackRock, Inc. | 9.90 | -88.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 68,899 | 205,610 | 33.51 | |
| 60,001 | 193,361 | 31.03 | |
| 50,847 | 185,323 | 27.44 | |
| 41,960 | 160,168 | 26.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| REPL – Replimune Group, Inc. | RGEN – Repligen Corporation |
| RGNX – REGENXBIO Inc. | RLMD – Relmada Therapeutics, Inc. |
| RLYB – Rallybio Corporation |